4,896
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Calcium Supplementation and Coronary Artery Disease: A Methodological Confound?

&

References

  • Wright NC, Saag KG, Dawson-Hughes B, Khosla S, Siris ES. The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA. Osteoporos Int. 2017;28(4):1225–1232. doi:10.1007/s00198-016-3865-3.
  • Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus MJ, Harris ST, Jan de Beur SM, Khosla S, Lane NE. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int. 2014;25(5):1439–1443. doi:10.1007/s00198-014-2655-z.
  • Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–1733. doi:10.1007/s00198-006-0172-4.
  • Melton LJ, Atkinson EJ, O'Connor MK, O'Fallon WM, Riggs BL. Bone density and fracture risk in men. J Bone Miner Res. 1998;13(12):1915–1923. doi:10.1359/jbmr.1998.13.12.1915.
  • Melton LJ, Chrischilles EA, Cooper C, Lane AW, Riggs BL. Perspective. How many women have osteoporosis? J Bone Miner Res. 2009;7(9):1005–1010. doi:10.1002/jbmr.5650070902.
  • Kanis JA, Johnell O, Oden A, Sernbo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B. Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int J. 2000;11(8):669–674.
  • Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7(5):407–413. doi:10.1007/PL00004148.
  • Cooper C, Atkinson EJ, Jacobsen SJ, O’Fallon WM, Melton LJ. Population-based study of survival after osteoporotic fractures. Am J Epidemiol. 1993;137(9):1001–1005. doi:10.1093/oxfordjournals.aje.a116756.
  • Leibson CL, Tosteson ANA, Gabriel SE, Ransom JE, Melton LJ. Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc. 2002;50(10):1644–1650. doi:10.1046/j.1532-5415.2002.50455.x.
  • Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359–2381. doi:10.1007/s00198-014-2794-2.
  • Bailey RL, Dodd KW, Goldman JA, Gahche JJ, Dwyer JT, Moshfegh AJ, Sempos CT, Picciano MF. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr. 2010;140(4):817–822. doi:10.3945/jn.109.118539.
  • Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US adults use dietary supplements. JAMA Intern Med. 2013;173(5):355–361. doi:10.1001/jamainternmed.2013.2299.
  • Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SAA, Black HR, Blanchette P, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669–683. doi:10.1056/NEJMoa055218.
  • Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, LaCroix AZ, Anderson GL, Chlebowski RT, Manson JE, Van Horn L, Vitolins MZ, et al. Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study. Osteoporos Int. 2013;24(2):567–580. doi:10.1007/s00198-012-2224-2.
  • Kahwati LC, Weber RP, Pan H, Gourlay M, LeBlanc E, Coker-Schwimmer M, Viswanathan M. Vitamin D, Calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: Evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;319(15):1600. doi:10.1001/jama.2017.21640.
  • Newberry SJ, Chung M, Shekelle PG, Booth MS, Liu JL, Maher AR, Motala A, Cui M, Perry T, Shanman R, et al. Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update). Evid Rep Technol Assess. 2014:1–929. doi:10.23970/AHRQEPCERTA217.
  • Weaver CM, Alexander DD, Boushey CJ, Dawson-Hughes B, Lappe JM, LeBoff MS, Liu S, Looker AC, Wallace TC, Wang DD, et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int. 2016;27(1):367–376. doi:10.1007/s00198-015-3386-5.
  • Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, Hope S, Kanis JA, McCloskey EV, Poole KES, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2017;12(1):43. doi:10.1007/s11657-017-0324-5.
  • Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. Can Med Assoc J. 2010;182(17):1864–1873. doi:10.1503/cmaj.100771.
  • Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N, Ohta H, Shiraki M, Sugimoto T, Suzuki T, et al. Japanese 2011 guidelines for prevention and treatment of osteoporosis-executive summary. Arch Osteoporos. 2012;73–20. doi:10.1007/s11657-012-0109-9.
  • Calcium/Vitamin D requirements, recommended foods & supplements. National Osteoporosis Foundation. [accessed 2019 Aug 27]. https://www.nof.org/patients/treatment/calciumvitamin-d/.
  • Harvey NC, Biver E, Kaufman JM, Bauer J, Branco J, Brandi ML, Bruyère O, Coxam V, Cruz-Jentoft A, Czerwinski E, et al. The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF). Osteoporos Int J. 2017;28447–462.
  • Barbarawi M, Kheiri B, Zayed Y, Barbarawi O, Dhillon H, Swaid B, Yelangi A, Sundus S, Bachuwa G, Alkotob ML, et al. Vitamin D supplementation and cardiovascular disease risks in more than 83 000 individuals in 21 randomized clinical trials: A meta-analysis. JAMA Cardiol. 2019;4(8):765. doi:10.1001/jamacardio.2019.1870.
  • Bolland MJ, Barber PA, Doughty RN, Mason B, Horne A, Ames R, Gamble GD, Grey A, Reid IR. Vascular events in healthy older women receiving calcium supplementation: Randomised controlled trial. BMJ. 2008;336(7638):262–266. doi:10.1136/bmj.39440.525752.BE.
  • Reid IR, Ames R, Mason B, Reid HE, Bacon CJ, Bolland MJ, Gamble GD, Grey A, Horne A. Randomized Controlled Trial of Calcium Supplementation in Healthy, Nonosteoporotic, Older Men. Arch Intern Med. 2008;168(20):2276. doi:10.1001/archinte.168.20.2276.
  • Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341(jul29 1):c3691. doi:10.1136/bmj.c3691.
  • Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342(apr19 1):d2040. doi:10.1136/bmj.d2040.
  • Heaney RP, Kopecky S, Maki KC, Hathcock J, MacKay D, Wallace TC. A review of calcium supplements and cardiovascular disease risk. Adv Nutr. 2012;3(6):763–771. doi:10.3945/an.112.002899.
  • Nordin BEC, Lewis JR, Daly RM, Horowitz J, Metcalfe A, Lange K, Prince RL. The calcium scare–what would Austin Bradford Hill have thought? Osteoporos Int. 2011;22(12):3073–3077. doi:10.1007/s00198-011-1680-4.
  • Biggs WS. Data were misrepresented. BMJ. 2008;336(7641):404.1–404. doi:10.1136/bmj.39493.484086.1F.
  • Prince RL, Zhu K, Lewis JR. Evidence of harm is unconvincing. BMJ. 2011;342(jun07 1):d3541. doi:10.1136/bmj.d3541.
  • Penston J. Claims do not hold water. BMJ. 2011;342(jun07 1):d3543. doi:10.1136/bmj.d3543.
  • Metcalfe AV, Nordin BEC. A reanalysis too far? BMJ. 2011;342(jun07 1):d3538. doi:10.1136/bmj.d3538.
  • Black SL. Analysis of absolute incidence tells different story. BMJ. 2011;342(jun07 1):d3530. doi:10.1136/bmj.d3530.
  • Wilson C. Calcium supplements and osteoporosis: the heart of the matter. Nat Rev Endocrinol. 2011;7(7):373. doi:10.1038/nrendo.2011.82.
  • Wang L, Manson JE, Song Y, Sesso HD. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010;152(5):315–323. doi:10.7326/0003-4819-152-5-201003020-00010.
  • Chung M, Tang AM, Fu Z, Wang DD, Newberry SJ. Calcium intake and cardiovascular disease risk: An updated systematic review and meta-analysis. Ann Intern Med. 2016;165(12):856. doi:10.7326/M16-1165.
  • Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, Lichtenstein A, Patel K, Raman G, Tatsioni A, et al. Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess. 2009;(183):1–420.
  • Institute of Medicine (US). Committee to review dietary reference intakes for vitamin D and calcium; Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press (US); 2011.
  • Moyer VA, & U.S. Preventive Services Task Force. Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;158(9):691–696.
  • Phillips‐Eakley AK, McKenney‐Drake ML, Bahls M, Newcomer SC, Radcliffe JS, Wastney ME, Van Alstine WG, Jackson G, Alloosh M, Martin BR, et al. Effect of high‐calcium diet on coronary artery disease in Ossabaw miniature swine with metabolic syndrome. J Am Heart Assoc. 2015;4(8):e001620.
  • Kopecky SL, Bauer DC, Gulati M, Nieves JW, Singer AJ, Toth PP, Underberg JA, Wallace TC, Weaver CM. Lack of evidence linking calcium with or without Vitamin D supplementation to cardiovascular disease in generally healthy adults: A clinical guideline from the National Osteoporosis Foundation and the American Society for Preventive Cardiology. Ann Intern Med. 2016;165(12):867. doi:10.7326/M16-1743.
  • Heaney RP, Saville PD, Recker RR. Calcium absorption as a function of calcium intake. J Lab Clin Med. 1975;85(6):881–890.
  • Blumberg J, Heaney RP, Huncharek M, Scholl T, Stampfer M, Vieth R, Weaver CM, Zeisel SH. Evidence-based criteria in the nutritional context: Nutrition Reviews©. Nutr Rev. 2010;68(8):478–484. doi:10.1111/j.1753-4887.2010.00307.x.
  • West SL, Swan VJD, Jamal SA. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population. Clin J Am Soc Nephrol CJASN. 2010;5(Supplement 1):S41–S47.
  • Shao J-S, Cheng S-L, Sadhu J, Towler DA. Inflammation and the osteogenic regulation of vascular calcification: A review and perspective. Hypertension. 2010;55(3):579–592.
  • Burt MG, Mangelsdorf BL, Srivastava D, Petersons CJ. Acute effect of calcium citrate on serum calcium and cardiovascular function. J Bone Miner Res. 2013;28(2):412–418. doi:10.1002/jbmr.1761.
  • Samelson EJ, Booth SL, Fox CS, Tucker KL, Wang TJ, Hoffmann U, Cupples LA, O’Donnell CJ, Kiel DP. Calcium intake is not associated with increased coronary artery calcification: the Framingham Study. Am J Clin Nutr. 2012;96(6):1274–1280. doi:10.3945/ajcn.112.044230.
  • Larsson SC, Burgess S, Michaëlsson K. Association of genetic variants related to serum calcium levels with coronary artery disease and myocardial infarction. JAMA. 2017;318(4):371. doi:10.1001/jama.2017.8981.
  • Samozai MN, Kulkarni AK. Do calcium supplements increase serum and urine calcium levels in post-menopausal women? J Nutr Health Aging. 2015;19(5):537–541. doi:10.1007/s12603-014-0532-2.
  • Dawson-Hughes B, Harris SS, Palermo NJ, Castaneda-Sceppa C, Rasmussen HM, Dallal GE. Treatment with potassium bicarbonate lowers calcium excretion and bone resorption in older men and women. J Clin Endocrinol Metab. 2009;94(1):96–102. doi:10.1210/jc.2008-1662.
  • Weaver CM, & Heaney RP. Food sources, supplements, and bioavailability. In: Weaver CM, Heaney RP, editors. Calcium in human health. Totowa, NJ: Humana Press; 2006. p. 129–142. doi:10.1007/978-1-59259-961-5_9.
  • U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans. 8th ed. 2015 Dec. Available from: http://health.gov/dietaryguidelines/2015/guidelines/.
  • Weaver CM. Calcium supplementation: Is protecting against osteoporosis counter to protecting against cardiovascular disease? Curr Osteoporos Rep. 2014;12(2):211–218. doi:10.1007/s11914-014-0208-1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.